Latin America & Caribbean (excluding high income) vs Togo: Antiretroviral therapy coverage

Latin America & Caribbean (excluding high income)
71.8%
in 2024
Togo
92.0%
in 2024
Latin America & Caribbean (excluding high income) rank
17th
Togo rank
14th

Antiretroviral therapy coverage over time

  • Latin America & Caribbean (excluding high income)
  • Togo
020406080100200020122024

How they compare

Togo currently reports 92.0% against 71.8% in Latin America & Caribbean (excluding high income), a difference of 20.2%.

That makes Togo's figure about 1.3 times Latin America & Caribbean (excluding high income)'s.

The two have swapped places 1 time across 25 shared years of data; in 2000 it was Latin America & Caribbean (excluding high income) ahead.

Latin America & Caribbean (excluding high income) ranks 17th and Togo ranks 14th of 23 groups.

Across the 3 decades both report, Latin America & Caribbean (excluding high income) averaged higher in 2 and Togo in 1.

Head to head by decade

Decade Latin America & Caribbean (excluding high income) Togo Difference Ahead
2000s 20.9% 4.6% 16.3% Latin America & Caribbean (excluding high income)
2010s 48.5% 44.8% 3.7% Latin America & Caribbean (excluding high income)
2020s 68.2% 84.0% 15.8% Togo

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Latin America & Caribbean (excluding high income) or Togo?
Togo, at 92.0% against 71.8% in Latin America & Caribbean (excluding high income) as of 2024.
What is the difference in antiretroviral therapy coverage between Latin America & Caribbean (excluding high income) and Togo?
20.2%, with Togo ahead.
How many years of comparable data are there for Latin America & Caribbean (excluding high income) and Togo?
25 years are reported by both, from 2000 to 2024.
How do Latin America & Caribbean (excluding high income) and Togo rank globally for antiretroviral therapy coverage?
Latin America & Caribbean (excluding high income) ranks 17th and Togo ranks 14th of 23 groups.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Latin America & Caribbean (excluding high income) vs Togo: Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/latin-america-and-caribbean-excluding-high-income/togo/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/latin-america-and-caribbean-excluding-high-income/togo/">Latin America & Caribbean (excluding high income) vs Togo: Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.